Skip to main content

Advertisement

Articles

Page 3 of 8

  1. In 2013, 78% of malaria deaths occurred in children aged 5 years and below, in sub-Saharan Africa. Treatment of severe malaria requires a health facility with inpatient care. However, in most sub-Sahara Africa...

    Authors: Vivian Rakuomi, Faith Okalebo, Stanley Ndwigah and Levi Mbugua

    Citation: Cost Effectiveness and Resource Allocation 2017 15:14

    Content type: Research

    Published on:

  2. This study evaluated the potential cost-effectiveness of cervical cancer screening in HIV treatment clinics in Nairobi, Kenya.

    Authors: Marita R. Zimmermann, Elisabeth Vodicka, Joseph B. Babigumira, Timothy Okech, Nelly Mugo, Samah Sakr, Louis P. Garrison and Michael H. Chung

    Citation: Cost Effectiveness and Resource Allocation 2017 15:13

    Content type: Research

    Published on:

  3. Innovations that improve the affordability, accessibility, or effectiveness of health care played a major role in the Millennium Development Goal achievements and will be critical for reaching the ambitious ne...

    Authors: Tara Herrick, Claudia Harner-Jay, Craig Shaffer, Greg Zwisler, Peder Digre and Amie Batson

    Citation: Cost Effectiveness and Resource Allocation 2017 15:12

    Content type: Research

    Published on:

  4. In Italy HPV vaccination with the quadrivalent vaccine (Gardasil®) is offered actively and free of charge to girls aged 12 since 2007. A nine-valent vaccine (Gardasil 9®) received the European market authorizatio...

    Authors: Francesco Saverio Mennini, Paolo Bonanni, Florence Bianic, Chiara de Waure, Gianluca Baio, Giacomo Plazzotta, Mathieu Uhart, Alessandro Rinaldi and Nathalie Largeron

    Citation: Cost Effectiveness and Resource Allocation 2017 15:11

    Content type: Research

    Published on:

  5. Malaria continues to be a public health problem despite past and on-going control efforts. For sustenance of control efforts to achieve the malaria elimination goal, it is important that the most cost-effectiv...

    Authors: Resign Gunda and Moses John Chimbari

    Citation: Cost Effectiveness and Resource Allocation 2017 15:10

    Content type: Review

    Published on:

  6. This study evaluates the cost-effectiveness of the DAZT program for scaling up treatment of acute child diarrhea in Gujarat India using a net-benefit regression framework.

    Authors: Samuel D. Shillcutt, Amnesty E. LeFevre, Christa L. Fischer-Walker, Sunita Taneja, Robert E. Black and Sarmila Mazumder

    Citation: Cost Effectiveness and Resource Allocation 2017 15:9

    Content type: Research

    Published on:

  7. Ofatumumab (Arzerra®, Novartis) is a treatment for chronic lymphocytic leukemia refractory to fludarabine and alemtuzumab [double refractory (DR-CLL)]. Ofatumumab was licensed on the basis of an uncontrolled Phas...

    Authors: Anthony J. Hatswell, Gwilym J. Thompson, Penny A. Maroudas, Oleg Sofrygin and Thomas E. Delea

    Citation: Cost Effectiveness and Resource Allocation 2017 15:8

    Content type: Methodology

    Published on:

  8. This study aims to summarise and describe the evolution of published economic evaluations of vaccines in Canada, thereby outlining the current state of this expanding and meaningful research.

    Authors: Ellen R. S. Rafferty, Heather L. Gagnon, Marwa Farag and Cheryl L. Waldner

    Citation: Cost Effectiveness and Resource Allocation 2017 15:7

    Content type: Review

    Published on:

  9. This study is an initial effort to examine the dynamics of efficiency and productivity in Greek public hospitals during the first phase of the crisis 2009–2012. Data were collected by the Ministry of Health af...

    Authors: P. Xenos, J. Yfantopoulos, M. Nektarios, N. Polyzos, P. Tinios and A. Constantopoulos

    Citation: Cost Effectiveness and Resource Allocation 2017 15:6

    Content type: Research

    Published on:

  10. Mobile and wireless technology for health (mHealth) has the potential to improve health outcomes by addressing critical health systems constraints that impede coverage, utilization, and effectiveness of health...

    Authors: Amnesty E. LeFevre, Samuel D. Shillcutt, Sean Broomhead, Alain B. Labrique and Tom Jones

    Citation: Cost Effectiveness and Resource Allocation 2017 15:5

    Content type: Methodology

    Published on:

  11. In resource-limited settings with a high prevalence of human immunodeficiency virus (HIV) infection such as Zambia, decentralization of HIV/acquired immunodeficiency syndrome (HIV/AIDS) treatment and care with...

    Authors: Shinsuke Miyano, Gardner Syakantu, Kenichi Komada, Hiroyoshi Endo and Tomohiko Sugishita

    Citation: Cost Effectiveness and Resource Allocation 2017 15:4

    Content type: Research

    Published on:

  12. Health care systems around the world have started to develop pharmacists prescribing for minor ailments (PPMA) programs. These programs aim to improve the efficiency of care, reduce physician visits, and incre...

    Authors: Ellen Rafferty, Mohsen Yaghoubi, Jeff Taylor and Marwa Farag

    Citation: Cost Effectiveness and Resource Allocation 2017 15:3

    Content type: Research

    Published on:

  13. Neonatal mortality remains unacceptably high in many low and middle-income countries, including India. A community mobilisation intervention using participatory learning and action with women’s groups facilita...

    Authors: Rajesh Kumar Sinha, Hassan Haghparast-Bidgoli, Prasanta Kishore Tripathy, Nirmala Nair, Rajkumar Gope, Shibanand Rath and Audrey Prost

    Citation: Cost Effectiveness and Resource Allocation 2017 15:2

    Content type: Research

    Published on:

  14. Economic evidence is influential in health technology assessment world-wide. Clinical Practice Guidelines (CPG) can enable economists to include economic information on health care provision. Application of ec...

    Authors: Kathryn M. Antioch, Michael F. Drummond, Louis W. Niessen and Hindrik Vondeling

    Citation: Cost Effectiveness and Resource Allocation 2017 15:1

    Content type: Review

    Published on:

  15. In Nepal, pre-eclampsia/eclampsia (PE/E) causes an estimated 21% of maternal deaths annually and contributes to adverse neonatal birth outcomes. Calcium supplementation has been shown to reduce the risk of PE/...

    Authors: Isabelle Feldhaus, Amnesty E. LeFevre, Chandra Rai, Jona Bhattarai, Deirdre Russo, Barbara Rawlins, Pushpa Chaudhary and Kusum Thapa

    Citation: Cost Effectiveness and Resource Allocation 2016 14:13

    Content type: Research

    Published on:

  16. Long-term care for older people is provided in both residential and non-residential settings, with residential settings tending to cater for individuals with higher care needs. Evidence relating to the costs a...

    Authors: Tiffany Easton, Rachel Milte, Maria Crotty and Julie Ratcliffe

    Citation: Cost Effectiveness and Resource Allocation 2016 14:12

    Content type: Review

    Published on:

  17. Zoledronic acid and denosumab were funded by the Australian government for the management of osteoporosis at an equivalent price to alendronate. The price of alendronate has declined by around 65 %, but the pr...

    Authors: Jonathan Karnon, Ainul Shakirah Shafie, Nneka Orji and Sofoora Kawsar Usman

    Citation: Cost Effectiveness and Resource Allocation 2016 14:11

    Content type: Research

    Published on:

  18. The coverage of prevention and treatment strategies for ischemic heart disease and stroke is very low in Ethiopia. In view of Ethiopia’s meager healthcare budget, it is important to identify the most cost-effe...

    Authors: Mieraf Taddesse Tolla, Ole Frithjof Norheim, Solomon Tessema Memirie, Senbeta Guteta Abdisa, Awel Ababulgu, Degu Jerene, Melanie Bertram, Kirsten Strand, Stéphane Verguet and Kjell Arne Johansson

    Citation: Cost Effectiveness and Resource Allocation 2016 14:10

    Content type: Research

    Published on:

  19. Human papilloma virus (HPV) vaccination in Nigeria will require substantial financing due to high cost of HPV vaccine and inexistence of structures to support adolescent vaccination. Alternative sources are ne...

    Authors: Ifeoma Blessing Umeh, Sunday Odunke Nduka and Obinna Ikechukwu Ekwunife

    Citation: Cost Effectiveness and Resource Allocation 2016 14:8

    Content type: Research

    Published on:

  20. To conduct a cost-utility analysis of ranibizumab versus aflibercept for the treatment of patients with visual impairment due to diabetic macular edema (DME) in the Greek setting.

    Authors: Georgia Kourlaba, John Relakis, Ronan Mahon, Maria Kalogeropoulou, Georgia Pantelopoulou, Olga Kousidou and Nikos Maniadakis

    Citation: Cost Effectiveness and Resource Allocation 2016 14:7

    Content type: Research

    Published on:

  21. The objective of this analysis was to determine the value (incremental cost/increment benefit) of a brain LITT system versus employing current surgical options recommended by NCCN guidelines, specifically open...

    Authors: Jeffrey D. Voigt and Gene Barnett

    Citation: Cost Effectiveness and Resource Allocation 2016 14:6

    Content type: Research

    Published on:

  22. The editors of Cost Effectiveness and Resource Allocation would like to thank all our reviewers who have contributed to the journal in volume 13 (2015).

    Authors: Joan Rovira

    Citation: Cost Effectiveness and Resource Allocation 2016 14:5

    Content type: Reviewer acknowledgement

    Published on:

  23. Streptococcus pneumoniae is a common cause of child death. However, the economic burden of pneumococcal disease in low-income countries is poorly described. We aimed to estimate from a...

    Authors: Effua Usuf, Grant Mackenzie, Sana Sambou, Deborah Atherly and Chutima Suraratdecha

    Citation: Cost Effectiveness and Resource Allocation 2016 14:4

    Content type: Research

    Published on:

  24. Newborn mortality, comprising a third of all under-5 deaths, has hardly changed in low and middle income countries (LMICs) including South Africa over the past decade. To attain the MDG 4 target, greater empha...

    Authors: Mandy Maredza, Lumbwe Chola and Karen Hofman

    Citation: Cost Effectiveness and Resource Allocation 2016 14:2

    Content type: Review

    Published on:

  25. Despite improvements in a number of health outcome indicators partly due to the National Health Insurance Scheme (NHIS), Ghana is unlikely to attain all its health-related millennium development goals before t...

    Authors: Robert Kaba Alhassan, Edward Nketiah-Amponsah, James Akazili, Nicole Spieker, Daniel Kojo Arhinful and Tobias F Rinke de Wit

    Citation: Cost Effectiveness and Resource Allocation 2015 13:23

    Content type: Research

    Published on:

  26. The cost-effectiveness of umeclidinium bromide-vilanterol (UMEC/VI) versus tiotropium monotherapy in the UK was assessed using a UMEC/VI treatment-specific economic model based on a chronic obstructive pulmona...

    Authors: Yogesh Suresh Punekar, Graeme Roberts, Afisi Ismaila and Martin O’Leary

    Citation: Cost Effectiveness and Resource Allocation 2015 13:22

    Content type: Research

    Published on:

  27. All international guidelines suggested that Tenofovir and Entecavir are the primary drugs at the first line therapy for the treatment of chronic hepatitis B (CHB). However, in Turkey these medications reimburs...

    Authors: Guvenc Kockaya, Akin Kose, Fatma Betul Yenilmez, Oktay Ozdemir and Ece Kucuksayrac

    Citation: Cost Effectiveness and Resource Allocation 2015 13:21

    Content type: Research

    Published on:

  28. The rapid and continuous growth of health care cost aggravates the frequently low priority and less attention given in financing laboratory services. The poorest countries have the highest out-of-pocket spend...

    Authors: Kasaw Adane, Zenegnaw Abiy and Kassu Desta

    Citation: Cost Effectiveness and Resource Allocation 2015 13:20

    Content type: Research

    Published on:

  29. In the Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST elevation myocardial infarction (FAMOUS) clinical trial, FFR was shown to significantly reduce coro...

    Authors: Julian Nam, Andrew Briggs, Jamie Layland, Keith G. Oldroyd, Nick Curzen, Arvind Sood, Kanarath Balachandran, Raj Das, Shahid Junejo, Hany Eteiba, Mark C. Petrie, Mitchell Lindsay, Stuart Watkins, Simon Corbett, Brian O’Rourke, Anna O’Donnell…

    Citation: Cost Effectiveness and Resource Allocation 2015 13:19

    Content type: Research

    Published on:

  30. Sequential treatment of ankylosing spondylitis (AS) that includes tumour necrosis factor-α antagonists (anti-TNF agents) has been applied in most of the Western countries. Existing cost-effectiveness (CE) mode...

    Authors: An Tran-Duy, Annelies Boonen, Mart A. F. J. van de Laar and Johan L. Severens

    Citation: Cost Effectiveness and Resource Allocation 2015 13:18

    Content type: Research

    Published on:

  31. In the US, the prevalence of hepatitis C virus (HCV) has surpassed the prevalence of human immunodeficiency virus (HIV), with about 3.3 million people chronically infected with the disease. Given the aging of ...

    Authors: Jennifer M. Poonsapaya, Michael Einodshofer, Heather S. Kirkham, Pheophilus Glover and Janeen DuChane

    Citation: Cost Effectiveness and Resource Allocation 2015 13:17

    Content type: Research

    Published on:

  32. Prepaid contributory systems are increasingly being recognized as key mechanisms in achieving universal health coverage in low and middle-income countries. Peru created the Seguro Integral de Salud (SIS) to in...

    Authors: Daniel Cobos Muñoz, Kristian Schultz Hansen, Fern Terris-Prestholt, Fiona Cianci, José Enrique Pérez-Lu, Aldo Lama and Patricia J. García

    Citation: Cost Effectiveness and Resource Allocation 2015 13:16

    Content type: Research

    Published on:

  33. After implementation of the PREDICA annual chest X-ray (CXR) screening program in smokers in the general practice setting of Varese-Italy a significant reduction in lung cancer-specific mortality (18 %) was ob...

    Authors: Paolo Pertile, Albino Poli, Lorenzo Dominioni, Nicola Rotolo, Elisa Nardecchia, Massimo Castiglioni, Massimo Paolucci, William Mantovani and Andrea Imperatori

    Citation: Cost Effectiveness and Resource Allocation 2015 13:15

    Content type: Research

    Published on:

  34. This study was carried out at district level to describe the cost structure and measure the effectiveness of delivering supplementary immunization activity (SIA) and routine immunization (RI) for measles in Be...

    Authors: Landry Kaucley and Pierre Levy

    Citation: Cost Effectiveness and Resource Allocation 2015 13:14

    Content type: Research

    Published on:

  35. Tiotropium (TIO) is a well-established bronchodilator, LAMA (long-acting anticholinergic), for the treatment of moderate to very severe chronic obstructive pulmonary disease (COPD). Clinical evidence suggests ...

    Authors: Oskar Eklund, Faraz Afzal and Fredrik Borgström

    Citation: Cost Effectiveness and Resource Allocation 2015 13:13

    Content type: Research

    Published on:

  36. For end-users of diabetes models that include UKPDS 82 risk equations, an important question is how well these new equations perform. Consequently, the principal objective of this study was to validate the UKP...

    Authors: Philip McEwan, Thomas Ward, Hayley Bennett and Klas Bergenheim

    Citation: Cost Effectiveness and Resource Allocation 2015 13:12

    Content type: Research

    Published on:

  37. Certolizumab pegol, a PEGylated tumour necrosis factor (TNF)-inhibitor, improves the clinical signs and symptoms of rheumatoid arthritis (RA) when used in combination with methotrexate or as monotherapy. This ...

    Authors: Álvaro Hidalgo-Vega, Renata Villoro, Juan Antonio Blasco, Pablo Talavera, Belén Ferro and Oana Purcaru

    Citation: Cost Effectiveness and Resource Allocation 2015 13:11

    Content type: Research

    Published on:

  38. The aim of this study was to compare the cost-utility of the first available single-pill triple combination antihypertensive therapy containing valsartan (V), amlodipine (A) and hydrochlorothiazide (H), with e...

    Authors: Panagiotis Stafylas, Georgia Kourlaba, Magda Hatzikou, Dimitrios Georgiopoulos, Pantelis Sarafidis and Nikolaos Maniadakis

    Citation: Cost Effectiveness and Resource Allocation 2015 13:10

    Content type: Research

    Published on:

  39. Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder which can affect multiple organs of the body, requiring ongoing disease management and healthcare resource utilization. The economic impact o...

    Authors: Cindy Garris, Manan Shah and Eileen Farrelly

    Citation: Cost Effectiveness and Resource Allocation 2015 13:9

    Content type: Research

    Published on:

  40. Globally, diarrhoea is the second leading cause of morbidity and mortality, responsible for the annual loss of about 10% of the total global childhood disease burden. In Tanzania, Rotavirus infection is the ma...

    Authors: George M Ruhago, Frida N Ngalesoni, Bjarne Robberstad and Ole F Norheim

    Citation: Cost Effectiveness and Resource Allocation 2015 13:7

    Content type: Research

    Published on:

  41. Pneumococcal diseases in children under five years are common and preventable. In Colombia there are two pneumococcal conjugate vaccines (PCV) that have proved clinical efficacy. The aim was to estimate the co...

    Authors: Jaime E Ordóñez and John Jairo Orozco

    Citation: Cost Effectiveness and Resource Allocation 2015 13:6

    Content type: Research

    Published on:

  42. In 2004, the largest HIV prevention project (Avahan) conducted globally was implemented in India. Avahan was implemented by NGOs supported by state lead partners in order to provide HIV prevention services to ...

    Authors: Aurélia Lépine, Anna Vassall and Sudhashree Chandrashekar

    Citation: Cost Effectiveness and Resource Allocation 2015 13:5

    Content type: Research

    Published on:

  43. The purpose of this study was to assess the consequences of a national immunization program with HPV vaccine for both boys and girls in Denmark, including the prophylactic effects on all potentially vaccine pr...

    Authors: Jens Olsen and Tine Rikke Jørgensen

    Citation: Cost Effectiveness and Resource Allocation 2015 13:4

    Content type: Research

    Published on:

  44. This paper examines the cost-effectiveness of achieving increases in the use of oral rehydration solution and zinc supplementation in the management of acute diarrhea in children under 5 years through social f...

    Authors: David Bishai, Karampreet Sachathep, Amnesty LeFevre, Hnin New Nwe Thant, Min Zaw, Tin Aung, Willi McFarland and Dominic Montagu

    Citation: Cost Effectiveness and Resource Allocation 2015 13:3

    Content type: Research

    Published on:

  45. Efficient and evidence-based medical device and equipment prioritization is of particular importance in low-income countries due to constraints in financing capacity, physical infrastructure and human resource...

    Authors: Richard J Lilford, Samantha L Burn, Karin D Diaconu, Peter Lilford, Peter J Chilton, Victoria Bion, Carole Cummins and Semira Manaseki-Holland

    Citation: Cost Effectiveness and Resource Allocation 2015 13:2

    Content type: Research

    Published on:

  46. Understanding the cost-effectiveness and affordability of interventions to reduce maternal and newborn deaths is critical to persuading policymakers and donors to implement at scale. The effectiveness of commu...

    Authors: Tim Colbourn, Anni-Maria Pulkki-Brännström, Bejoy Nambiar, Sungwook Kim, Austin Bondo, Lumbani Banda, Charles Makwenda, Neha Batura, Hassan Haghparast-Bidgoli, Rachael Hunter, Anthony Costello, Gianluca Baio and Jolene Skordis-Worrall

    Citation: Cost Effectiveness and Resource Allocation 2015 13:1

    Content type: Research

    Published on:

Annual Journal Metrics

Advertisement